<--- Back to Details
First PageDocument Content
Bristol-Myers Squibb / Amides / Dipeptidyl peptidase-4 inhibitors / Nitriles / Metformin / Dapagliflozin / Anti-diabetic medication / Sulfonylurea / Saxagliptin / Chemistry / Organic chemistry / Anti-diabetic drugs
Date: 2015-04-22 23:39:46
Bristol-Myers Squibb
Amides
Dipeptidyl peptidase-4 inhibitors
Nitriles
Metformin
Dapagliflozin
Anti-diabetic medication
Sulfonylurea
Saxagliptin
Chemistry
Organic chemistry
Anti-diabetic drugs

Add to Reading List

Source URL: www.pbs.gov.au

Download Document from Source Website

File Size: 61,67 KB

Share Document on Facebook

Similar Documents

Att vara eller inte vara .... trender inom läkemedelsforskning Anders Ekblom Mölndal 2 December 2013

Att vara eller inte vara .... trender inom läkemedelsforskning Anders Ekblom Mölndal 2 December 2013

DocID: 1gs0F - View Document

Forxiga, INN-dapagliflozin

Forxiga, INN-dapagliflozin

DocID: 1eAhO - View Document

Medicine / Organochlorides / Sulfonylureas / Diabetes / Guanidines / Metformin / Dapagliflozin / Sitagliptin / Glibenclamide / Chemistry / Organic chemistry / Anti-diabetic drugs

5.4 EMPAGLIFLOZIN, oral tablet, 10 mg, 25 mg, Jardiance®, Boehringer Ingelheim Pty Ltd Purpose of Application This submission seeks an Authority required listing for empagliflozin (Jardiance®) for the treatment of typ

DocID: 17Ihe - View Document

Health / Metformin / Sulfonylurea / Dapagliflozin / Diabetes mellitus type 2 / Diabetes mellitus / Glycated hemoglobin / Diabetes / Endocrine system / Medicine

6.3 DAPAGLIFLOZIN, 10 mg tablet, Forxiga®, AstraZeneca Pty Ltd 1 Purpose of Application To request amendments to the current restriction for dapagliflozin for use in diabetes mellitus type 2 (T2DM) to provide prescribe

DocID: 17FDZ - View Document

Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that

Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that

DocID: 177rO - View Document